In partnership with
Bullish Trend Led by HALO & KN Amid S&P Bearish Sentiment ā Halozyme Gains FDA Approval; Syntiant Acquires Knowlesā MEMS Division; S&P 500 Shows Mixed Short-Term Outlook.
At the end of the year, StockNews.AI Team wants to thank you for all your support in 2024 and wish you a bright and happy 2025!
In case youāre new to us, weāre excited to announce a game-changing analytic dashboard exclusively for our Premium and Pro members, designed to deliver insights that matter most. This new feature provides a streamlined overview of key financial data and trends at daily, weekly, monthly, quarterly, and yearly intervals.
This intuitive dashboard enables you to make quick, informed decisions, saving time and optimizing your financial strategies. Explore it on your desktop for more insights!
Hands Down Some Of The Best 0% Interest Credit Cards
Pay no interest until nearly 2027 with some of the best hand-picked credit cards this year. They are perfect for anyone looking to pay down their debt, and not add to it!
Click here to see what all of the hype is about.
Remember to move the mail to the Primary inbox if this mail is in other inboxes.
Hereāre the stocks with notable attention/movement for today, 12/30.
Hereās a breakdown of key stock events for today, 12/30.
Top 3 news you canāt miss for today, 12/30.
New York Post
BearishShortTermS&P 500Market Recap
Dow plunges more than 600 as Santa Claus rally fizzles
- Wall Street indexes opened sharply lower, lowest in over a week.
- S&P 500 fell 1.51%, reflecting broad sector declines.
- Treasury yields near highs pressure equity prices.
- Thin trading volumes expected till New Year holiday.
- Boeing and crypto stocks notably underperform amid broader market weakness.
PRNewsWire
VeryBullishLongTermHALOFDA Approval
Halozyme Announces FDA Approval of Bristol Myers Squibb's Opdivo Qvantigā¢ with ENHANZEĀ® for Subcutaneous Use in Most Previously Approved Adult Solid Tumor OpdivoĀ® (nivolumab) Indications
- Halozyme's ENHANZE technology used in FDA-approved Opdivo Qvantig for subcutaneous use.
- Opdivo Qvantig offers faster administration, taking 3-5 minutes versus 30 minutes for IV.
- FDA approval based on Phase 3 trial showing similar efficacy to IV Opdivo.
- Opdivo Qvantig improves patient flexibility and may reduce treatment burdens.
- Halozyme's ninth co-formulated product showcases their innovative drug delivery technology.
GlobeNewsWire
BullishLongTermKNM&A
Syntiant Completes Acquisition of Knowles' Consumer MEMS Microphone Division
- Syntiant acquired Knowles' MEMS microphone division for $150 million.
- Knowles CMM generated approximately $256 million in revenue in 2023.
- Acquisition enhances Syntiant's position in the growing MEMS microphone market.
- Syntiant aims to accelerate audio solutions using advanced sensors and AI models.
- Investment from Khazanah Nasional supports technological advancements in Malaysia.
Like StockNews.AI? Unlock more functions by joining our Premium or Pro Plan š š
Disclaimer: The content provided in this Email should be used for informational purposes only and in no way should be relied upon for financial advice.
This intuitive dashboard enables you to make quick, informed decisions, saving time and optimizing your financial strategies. Explore it on your desktop for more insights!
Remember to move the mail to the Primary inbox if this mail is in other inboxes.
Hereāre the stocks with notable attention/movement for today, 12/23.
Hereās a breakdown of key stock events for today, 12/23.
Top 3 news you canāt miss for today, 12/23.
CNBC
VeryBullishLongTermJWNM&A
Nordstrom to go private in $6.25 billion deal with founding family, Mexican retailer
- Nordstrom plans to go private with a $6.25 billion buyout deal.
- Nordstrom family will hold 50.1% ownership after the buyout.
- NvCurrent shareholders will receive $24.25 per share in cash.
- Nordstrom previously attempted to go private in 2018 but failed.
- The company forecasts a potentially soft holiday season ahead.
Market Watch
BullishShortTermHMCM&A
Honda and Nissan have made merger talks official. Why Honda's U.S.-listed shares are flying.
- Honda achieved a significant one-day percentage gain.
- This could indicate positive market sentiment around HMC's performance.
Market Watch
BearishShortTermMSTRCorporate Developments
MicroStrategy paid well over $100,000 per coin in its latest bitcoin purchases - MarketWatch
- MicroStrategy sold 1.3 million shares raising $561 million.
- Proceeds were used to buy 5,262 bitcoins at $106,662 each.
- Stock plummeted 2% amid a broader market downturn in MSTR.
- Bitcoin trading below $95,000 may pressure future purchases.
- MSTR's stock surged 476.6% in 2024 but dropped 23% since November.
Like StockNews.AI? Unlock more functions by joining our Premium or Pro Plan š š
Disclaimer: The content provided in this Email should be used for informational purposes only and in no way should be relied upon for financial advice.
Reply